Literature DB >> 19887086

Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.

Tiffany G Sheu1, Varough M Deyde, Rebecca J Garten, Alexander I Klimov, Larisa V Gubareva.   

Abstract

We report here the design of a pyrosequencing approach for the detection of molecular markers of resistance to the neuraminidase inhibitors zanamivir and oseltamivir in influenza viruses of type B. Primers were designed to analyze the sequences at eight amino acid positions E119, R152, D198, I222, S250, H274, R371, and G402 (universal A/N2 numbering) in the neuraminidase (NA) which have been previously found to be associated with resistance or reduced susceptibility to oseltamivir and/or zanamivir in the NA inhibition assay. In addition, the designed primers could be utilized to the distinguish between the NAs of influenza B viruses from the two major lineages (Victoria and Yamagata) that have co-circulated globally in recent years, thus providing a valuable tool for virus strain surveillance. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887086     DOI: 10.1016/j.antiviral.2009.10.022

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  19 in total

1.  Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient.

Authors:  Rachel R Higgins; Melissa Beniprashad; Eddie Chong-King; Yan Li; Nathalie Bastien; Donald E Low; Jonathan B Gubbay
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

Review 2.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

3.  Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.

Authors:  Andrew J Burnham; Tatiana Baranovich; Bindumadhav M Marathe; Jianling Armstrong; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

4.  A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants.

Authors:  Vasiliy P Mishin; Tatiana Baranovich; Rebecca Garten; Anton Chesnokov; Anwar I Abd Elal; Michelle Adamczyk; Jennifer LaPlante; Kirsten St George; Alicia M Fry; John Barnes; Stephanie C Chester; Xiyan Xu; Jacqueline M Katz; David E Wentworth; Larisa V Gubareva
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

Review 5.  Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors.

Authors:  Margaret Okomo-Adhiambo; Tiffany G Sheu; Larisa V Gubareva
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

6.  Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.

Authors:  Varough M Deyde; Tiffany G Sheu; A Angelica Trujillo; Margaret Okomo-Adhiambo; Rebecca Garten; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

Review 7.  Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic.

Authors:  Swati Kumar; Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

8.  Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546.

Authors:  Arnab Basu; Gloria Komazin-Meredith; Courtney McCarthy; Aleksandar Antanasijevic; Steven C Cardinale; Rama K Mishra; Dale L Barnard; Michael Caffrey; Lijun Rong; Terry L Bowlin
Journal:  ACS Infect Dis       Date:  2017-04-03       Impact factor: 5.084

9.  Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial.

Authors:  John H Beigel; Weerawat Manosuthi; Joy Beeler; Yajing Bao; Melanie Hoppers; Kiat Ruxrungtham; Richard L Beasley; Michael Ison; Anchalee Avihingsanon; Marcelo H Losso; Nicholas Langlois; Justin Hoopes; H Clifford Lane; H Preston Holley; Christopher A Myers; Michael D Hughes; Richard T Davey
Journal:  Clin Infect Dis       Date:  2020-05-23       Impact factor: 9.079

10.  New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.

Authors:  Arnab Basu; Aleksandar Antanasijevic; Minxiu Wang; Bing Li; Debra M Mills; Jessica A Ames; Peter J Nash; John D Williams; Norton P Peet; Donald T Moir; Mark N Prichard; Kathy A Keith; Dale L Barnard; Michael Caffrey; Lijun Rong; Terry L Bowlin
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.